As the year comes to a close, let’s find out what the CLA co-founders, Marcele De Sanctis and Terry Coyne have to say about the year that was.
Read More
When I was just a boy, around the time I began high school, I was constantly reminded of basic pro social behaviours that as adults we accept as universal truths – treat others with respect, be kind to one another, be polite, bullying is wrong. So, you can imagine my astonishment when I first came to understand the global icon known as Michael Jordan.
CLA are weathering the storm as best we can. We are anchored by our desire to continue to make leaders and organisations great through leadership. The following newsletter provides some insight into what we’ve been up to over the last 6 months and we hope you find it insightful and interesting.
From late April to early June 2020, CLA interviewed and surveyed 30 leaders across Australia, ranging from CEOs, C-Suite leaders, executives, functional managers and business owners. As scientist-practitioners the goal of this research was to ‘take the pulse’ of leaders as they were experiencing this learning.
In March 2020, Centre for Leadership Advantage (CLA) were humbled to have placed 68th in The Australian Financial Review Fast Starter list for 2020, representing Australia’s fastest growing companies. Following on from an interview with CLA Co-Founder and CEO Dr Marcele De Sanctis earlier this month, CLA Client Partner Aliki Stathopoulos sat down with CLA Co-Founder and Org Psych veteran Terry Coyne. In this interview, Terry shares his vision for launching CLA, and after forty years in the industry, how he’s seen the landscape change.
In March 2020, Centre for Leadership Advantage (CLA) were humbled to have placed 68th in The Australian Financial Review Fast Starter list for 2020, representing Australia’s fastest growing companies. CLA Client Partner Aliki Stathopoulos took the time to speak with Co-Founder and CEO Dr Marcele De Sanctis about what this award means to her, and what she believes has led to the success of CLA.